Newly Diagnosed Bullous Pemphigoid in a Patient Receiving Sitagliptin
Bullous pemphigoid (BP) is the most common autoimmune skin blistering disorder in the general population. The disease often presents in the seventh and eighth decades of life. Several identified triggers contribute to the pathogenesis of BP. One of these triggers includes the dipeptidyl peptidase-4...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-11-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0508 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|